POLBF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
38.15M
Intraday BUY SELL Signals
VACBF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
76.17M
Intraday BUY SELL Signals
Interact to see
Advertisement

POLBF vs VACBF

Header iconPOLBF vs VACBF Comparison
Open Charts POLBF vs VACBFBanner chart's image
Poolbeg Pharma
PriceLoading...
Change-$0.00 (-0.00%)
Volume$50K
Capitalization38.15M
NYKODE THERAPEUTICS AS
PriceLoading...
Change-$0.00 (-0.00%)
Volume$1.03K
Capitalization76.17M
POLBF vs VACBF Comparison Chart in %
VACBF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
POLBF vs. VACBF commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is POLBF is a Hold and VACBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (POLBF: $0.04 vs. VACBF: $0.19)
Brand notoriety: POLBF and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: POLBF: 100% vs. VACBF: 106%
Market capitalization -- POLBF: $38.15M vs. VACBF: $76.17M
POLBF [@Biotechnology] is valued at $38.15M. VACBF’s [@Biotechnology] market capitalization is $76.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

POLBF’s FA Score shows that 1 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • POLBF’s FA Score: 1 green, 4 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, POLBF is a better buy in the long-term than VACBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VACBF’s TA Score shows that 1 TA indicator(s) are bullish.

  • VACBF’s TA Score: 1 bullish, 1 bearish.

Price Growth

POLBF (@Biotechnology) experienced а 0.00% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($76.2M) has a higher market cap than POLBF($38.2M). VACBF YTD gains are higher at: -21.927 vs. POLBF (-63.983).
POLBFVACBFPOLBF / VACBF
Capitalization38.2M76.2M50%
EBITDAN/A-14.42M-
Gain YTD-63.983-21.927292%
P/E RatioN/AN/A-
RevenueN/A6.77M-
Total CashN/A63.9M-
Total DebtN/A2.9M-
TECHNICAL ANALYSIS
Technical Analysis
POLBFVACBF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
8%
Bullish Trend 2 days ago
18%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
8%
Bullish Trend 2 days ago
10%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
VACBF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNVGY24.010.03
+0.13%
Lenovo Group Ltd.
HWKE0.10N/A
N/A
Hawkeye Systems, Inc.
BRYAF0.07N/A
N/A
Berjaya Corporation BHD
KURRY29.85N/A
N/A
Kuraray Co.
VTYB19.00N/A
N/A
Victory Bancorp Inc.

POLBF and

Correlation & Price change

A.I.dvisor tells us that POLBF and NNVC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POLBF and NNVC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POLBF
1D Price
Change %
POLBF100%
N/A
NNVC - POLBF
26%
Poorly correlated
-0.83%
BOLT - POLBF
26%
Poorly correlated
-0.76%
BEIGF - POLBF
25%
Poorly correlated
N/A
DSGN - POLBF
25%
Poorly correlated
+1.46%
ALXO - POLBF
22%
Poorly correlated
-2.86%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and HYPD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and HYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
HYPD - VACBF
32%
Poorly correlated
+7.20%
SPHRY - VACBF
27%
Poorly correlated
N/A
RVPH - VACBF
22%
Poorly correlated
-13.48%
ZBIO - VACBF
21%
Poorly correlated
+0.84%
POLBF - VACBF
2%
Poorly correlated
N/A
More